Home/Filings/4/0000790051-24-000168
4//SEC Filing

Zdimal Kevin P 4

Accession 0000790051-24-000168

CIK 0000790051other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 7:16 PM ET

Size

31.5 KB

Accession

0000790051-24-000168

Insider Transaction Report

Form 4
Period: 2024-07-26
Zdimal Kevin P
V.P. &Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-07-26$423.17/sh4,195$1,775,19835,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$110.79/sh+3,175$351,75838,816 total
  • Sale

    Common Stock

    2024-07-26$424.16/sh3,175$1,346,70835,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$161.41/sh+4,881$787,84240,522 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$161.41/sh+2,344$378,34537,985 total
  • Sale

    Common Stock

    2024-07-26$425.90/sh2,344$998,31035,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$150.00/sh+3,331$499,65038,972 total
  • Sale

    Common Stock

    2024-07-26$428.26/sh10$4,28335,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$110.79/sh+4,195$464,76439,836 total
  • Sale

    Common Stock

    2024-07-26$425.10/sh4,881$2,074,91335,641 total
  • Sale

    Common Stock

    2024-07-26$427.62/sh3,534$1,511,20935,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$150.00/sh+10$1,50035,651 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2024-07-267,3700 total
    Exercise: $110.79Exp: 2029-02-04Common Stock (7,370 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-267,2250 total
    Exercise: $161.41Exp: 2030-02-03Common Stock (7,225 underlying)
  • Sale

    Common Stock

    2024-07-26$426.38/sh3,331$1,420,27235,641 total
  • Exercise/Conversion

    Common Stock

    2024-07-26$150.00/sh+3,534$530,10039,175 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2024-07-266,8750 total
    Exercise: $150.00Exp: 2031-02-01Common Stock (6,875 underlying)
Footnotes (10)
  • [F1]This transaction was executed in multiple trades at prices ranging from $422.66 to $423.65. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F10]The option vested in three equal annual installments beginning on February 2, 2022.
  • [F2]This transaction was executed in multiple trades at prices ranging from $423.66 to $424.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]This transaction was executed in multiple trades at prices ranging from $424.58 to $425.52. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F4]This transaction was executed in multiple trades at prices ranging from $425.58 to $426.08. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F5]This transaction was executed in multiple trades at prices ranging from $426.08 to $426.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F6]This transaction was executed in multiple trades at prices ranging from $427.10 to $428.08. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  • [F7]The option vested in three equal annual installments beginning on February 5, 2020.
  • [F8]The transaction is the exercise of a derivative security.
  • [F9]The option vested in three equal annual installments beginning on February 4, 2021.

Issuer

CARLISLE COMPANIES INC

CIK 0000790051

Entity typeother

Related Parties

1
  • filerCIK 0001492140

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 7:16 PM ET
Size
31.5 KB